Continuous low dose methimazole provided better long-term thyroid control in patients with relapsed Graves’ disease than radioiodine therapy or a second methimazole course. Read the press release from Archives of Endocrinology and Metabolism journal! https://pressreleases.scielo.org/en/2026/07/01/continuous-low-dose-methimazole-improves-control-in-relapsed-graves-disease/